The contribution of science to technological innovation is subject of ongoing debate. In a recent study, our authors investigated how the value of patents depends on the scientific articles referenced and what role aspects such as basicness, novelty, and interdisciplinarity play in this.
CWTS' Leonie van Drooge has received the Moderna vaccine. She is not an army enthusiast, yet she is grateful to the US Dept. of Defense. Its agency DARPA funded Moderna in 2013 to further develop the then-novel mRNA technology. This blog looks into how DARPA does or doesn't solve challenges.
The closing and opening of schools during the COVID-19 pandemic caused much debate. How was scientific evidence used in the ensuing public discussion? Our authors searched for evidence in the news and on Twitter and looked at three countries in particular: the Netherlands, Spain, and South Africa.
Can excellent science be connected with successful research commercialisation? Top scientists winning prestigious Spinoza and Stevin prizes share some insights. Their ‘X factor’ achievements suggest that institutionalised research commercialisation can benefit from more personalised pathways.
A recently published paper on the role of gender in mentorship in science has triggered a lot of debate. In this blog post, Vincent Traag and Ludo Waltman contribute to this debate by emphasizing the importance of understanding the underlying causal mechanisms.
Scientific publishing has become a game between scientists and journals. Scientists try to convince the journals to publish their papers, while journals try to filter-out low-quality papers while being overwhelmed with too many submissions. Is there a smarter way? Honest signaling may be the key.
While the pandemic has led many to first seek biomedical and epidemiological expertise, we should be careful not to overlook inputs from different scientific fields that could provide important insights in the current crisis. Here are some early academic responses you might have missed.